AzTrials
AzTrials

Research institution

CHU de Reims Clinical Trials

Studies where CHU de Reims is the lead sponsor: what is enrolling now, by phase, condition and country.

276 registered studies

In numbers

Open to volunteers
43
Active
43
With results posted
0
All registered
276

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 43
  • Neuromuscular Disease in Post-Intensive Care Syndrome

    Feasibility Study on the Use of a Walking Exoskeleton in the Intensive Care Unit

    • Not yet recruiting
    • Age: 18 years and older
    • Medical device

    The purpose of this study is to evaluate the feasibility of using a lower-limb exoskeleton in the intensive care unit for early mobilization of participants with intensive care neuromyopathy.

    Trial name
    ExoRea (NCT07907237)
    Testing
    rehabilitation session assisted by an exoskeleton
    Volunteers
    30 people
    Sponsor
    CHU de Reims
    Can I take part? ExoRea
  • Chronic Obstructive Pulmonary Disease (COPD)

    Effect of Exercise Order During Pulmonary Rehabilitation on Muscle Strength in Patients With COPD

    • Recruiting
    • Age: 18 years and older

    Chronic Obstructive Pulmonary Disease (COPD) is a chronic multisystem disease frequently associated with peripheral muscle dysfunction, which is strongly linked to prognosis and survival.

    Trial name
    ISTOR-COPD (NCT07655011)
    Testing
    Pulmonary Rehabilitation - Strength First, Pulmonary Rehabilitation - Endurance First
    Where
    France
    Volunteers
    138 people
    Sponsor
    CHU de Reims
    Can I take part? ISTOR-COPD
  • Ventilator Associated Pneumonia

    Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

    • Recruiting
    • Age: 18 years and older
    • Medical device

    Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation.

    Trial name
    VAMPAIR (NCT06554327)
    Testing
    Multiplex PCR
    Where
    France
    Volunteers
    265 people
    Sponsor
    CHU de Reims
    Can I take part? VAMPAIR
  • Unruptured Intracranial Aneurysm

    MRI Analysis in the Growth of Cerebral Aneurysms

    • Recruiting
    • Age: 18 years and older

    An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown.

    Trial name
    EPICAVC (NCT06705452)
    Testing
    Additional 4D Flow MRI or additional 4D Flow sequence
    Where
    France
    Volunteers
    281 people
    Sponsor
    CHU de Reims
    Can I take part? EPICAVC
  • Alcohol Use Disorder

    Self-Concept and Autobiographical Memory in Alcohol Use Disorder

    • Recruiting
    • Age: 24 years and older
    • Lifestyle or therapy programme

    This study has two objectives. First, to evaluate the effectiveness of psychotherapy sessions based on self-concept and autobiographical memory in patients suffering from alcohol use disorders (AUD).

    Trial name
    CoSMA (NCT06985927)
    Testing
    psychotherapeutic sessions
    Where
    France
    Volunteers
    100 people
    Sponsor
    CHU de Reims
    Can I take part? CoSMA
  • Periodontitis, Gingivitis

    Intraoral Scanners as Periodontal and Dental Pathologies Diagnosis Tools

    • Recruiting
    • Age: 18 years and older
    • Pill or oral medicine

    Periodontal diseases and dental pathologies are highly prevalent oral diseases. Thirty-three to fifty percent of adult population presented at least one untreated caries and more than 50% of French population are affected by…

    Conditions
    Periodontitis, Gingivitis, Dental Caries, Diagnosis
    Trial name
    Odonto3D (NCT06006429)
    Testing
    Numerical dental impression by intraoral scanner
    Where
    France
    Volunteers
    30 people, healthy volunteers welcome
    Sponsor
    CHU de Reims
    Can I take part? Odonto3D
  • Shock, Right Ventricular Dysfunction

    Right Ventriculo-Arterial Coupling During Fluid Loading in ICU Patients

    • Recruiting
    • Age: 18 years and older
    • Observational study

    Preload responsiveness and venous congestion have largely been investigated independently in recent literature. However, recent data report a similar incidence of venous congestion regardless of fluid responsiveness status…

    Conditions
    Shock, Right Ventricular Dysfunction, Venous Congestion
    Trial name
    RVPA-FLICU (NCT07537621)
    Testing
    Echography
    Where
    France
    Volunteers
    100 people
    Sponsor
    CHU de Reims
    Can I take part? RVPA-FLICU
  • Juvenile Idiopathic Arthritis

    Sarcopenia and Juvenile Idiopathic Arthritis

    • Not yet recruiting
    • Age: 15 to 40 years

    Juvenile idiopathic arthritis (JIA) is a rare chronic inflammatory rheumatic disease that begins during childhood and may persist into adulthood in many patients.

    Trial name
    SAJI (NCT07634354)
    Testing
    Sarcopenia screening assessment
    Where
    France
    Volunteers
    200 people
    Sponsor
    CHU de Reims
    Can I take part? SAJI
  • Alcohol Use Disorder

    Social Cognition in Severe Alcohol Use Disorder

    • Recruiting
    • Age: 18 to 65 years
    • Lifestyle or therapy programme

    With 41,000 deaths per year, alcohol consumption is the second leading cause of preventable mortality in France. Nearly 3.4% of adults engage in excessive and chronic alcohol use, meeting criteria for Severe Alcohol Use Disorder…

    Trial name
    COSMO (NCT07464613)
    Testing
    Analysis of social functioning and social cognition processes
    Where
    France
    Volunteers
    60 people, healthy volunteers welcome
    Sponsor
    CHU de Reims
    Can I take part? COSMO
  • Diabetic Retinopathy, Retinal Vein Occlusion

    Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

    • Recruiting
    • Age: 18 years and older

    CD160 represents a new angiogenic factor as its specific engagement by an agonist monoclonal antibody directed against human CD160 reduced angiogenesis of endothelial cells with a distinct mechanism from current angiogenic…

    Trial name
    NCT03680794
    Testing
    sampling of ophthalmic liquid
    Where
    France
    Volunteers
    120 people
    Sponsor
    CHU de Reims
    Can I take part? NCT03680794

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in